Tandem Diabetes Care (TNDM) Shares Outstanding (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Shares Outstanding (Entity) for 14 consecutive years, with $69.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 2.97% year-over-year to $69.5 million; the trailing twelve-month figure through Jun 2026 stood at $69.5 million (up 2.97% YoY), and the FY2025 full-year result was $68.3 million, up 3.06% from the prior year.
• Shares Outstanding (Entity) climbed to $69.5 million in Q2 2026 per TNDM's latest filing, from $68.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $69.5 million in Q2 2026 and bottomed at $63.9 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $66.0 million across 5 years, with a median of $65.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) decreased 0.07% in 2024, then advanced 3.24% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $64.5 million in 2022, then climbed by 1.61% to $65.6 million in 2023, then gained by 1.09% to $66.3 million in 2024, then climbed by 3.06% to $68.3 million in 2025, then gained by 1.83% to $69.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $69.5 million, $68.5 million, and $68.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.